C71T
CANCELLED SECTION 71
06/02/2026
Voltar para busca
Dado oficial do USPTO
JARI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
10/07/2018
Data de registro
23/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/02/2026
Última transação
03/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
JOHNSON, AISHA CLARKE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Jiangsu Automation Research Institute
Representantes
Lianyungang Guangxin Shangbiao Shiwusuo
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Chemical preparations for medical or veterinary purposes for the prevention and treatment of cancer; balsamic preparations for medical purposes for the prevention and treatment of cancer; medicines for alleviating constipation; digestives for pharmaceutical purposes; laxative; ointments for pharmaceutical purposes for the prevention and treatment of cancer; tranquillizers; sedatives; soporific; biological preparations for medical purposes for the prevention and treatment of cancer; chemical preparations for medical purposes for the prevention and treatment of cancer; enzymes for medical purposes; pharmaceutical preparations in the form of injectiontabletaqueous formulationtincturecapsuleointmentfor the prevention and treatment of cancerfor the treatment of cardiovascular and cardiopulmonary disordersprevention and treatment of disorders of the nervous systemthe immune systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary systemfor the treatment of inflammatory disorders; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; anti-epileptic pharmaceutical preparations; anti-cancer preparations
Classe 42
Technical research in the field of pharmaceutical studies; technical project studiesin the field of pharmaceutical studies; scientific laboratory services; oil-well testing; geological prospecting; oil prospecting; computer programming; computer software design; consultancy in the design and development of computer hardware; maintenance of computer software; computer system analysis; computer system design; conversion of computer programs and dataother than physical conversion; monitoring of computer systems by remote access to ensure proper functioning; engineering; Providing quality checking and testing of products; Providing quality checking and testing of products in the field of engineering; Providing quality assessment services in the field of product engineering; quality control services for certification purposes in the field of engineering; updating of computer software; rental of computer software; recovery of computer data; creating and maintaining web sites for others; web site hosting services; installation of computer software; computer software consultancy
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/11/2019
FIMP
FINAL DISPOSITION PROCESSED
18/11/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
31/05/2019
PUBO
PUBLISHED FOR OPPOSITION
07/05/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/04/2019
NPUB
NOTICE OF PUBLICATION
17/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/03/2019
RFNP
REFUSAL PROCESSED BY IB
21/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/11/2018
RFRR
REFUSAL PROCESSED BY MPU
23/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2018
CNRT
NON-FINAL ACTION WRITTEN
08/11/2018
DOCK
ASSIGNED TO EXAMINER
27/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2018
FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
07/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/09/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
23/08/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace JARI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.